Tularemia Vaccine
Intranasal vaccination with Francisella novicida strain protects against tularemia
Published in Vaccine Weekly, May 31st, 2006
"Francisella tularensis is an intracellular Gram-negative bacterium that is the causative agent of tularemia and a potential bioweapon. We have characterized the efficacy of a defined F. novicida mutant (Delta iglC) as a live attenuated vaccine against subsequent intranasal challenge with the wild-type organism," scientists writing in the journal Infection and Immunity report.
"Animals primed with the F. novicida Delta iglC (KKF24) mutant induced robust...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-05-31)
More Articles from Vaccine Weekly
- Chancroid Vaccine
Haemophilus ducreyi hemoglobin receptor protects against chancroid - Drug Development
Directed antigen delivery is vaccine strategy for intracellular bacterial pathogens - Environmental Health
Soot immunization elicits antibodies against polycyclic aromatic hydrocarbons - Epidemiology
Pneumococcal conjugate vaccine reduces invasive pneumococcal disease among infants - Pneumococcal Vaccine
DNA vaccines expressing pneumococcal surface protein A are as protective as recombinant protein - Alzheimer Disease
Anti-A-beta antibodies do not prevent neurofibrillary tangle formation - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
